Abiopharma

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

Avalo Therapeutics to Join the Russell2000® and Russell 3000® Indexes

Japanese Patent Allowance for Namodenosons Anti-Obesity Technology

New Autism Research to be Presented at European Purine Scientific Meeting

VENU CEO J.W. Roth Featured on The Business Digest Radio Show & Podcast

Catalyst Bancorp, Inc. and Lakeside Bancshares, Inc. Announce Shareholder and Regulatory Approvals for Pending Mergers

Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors

Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026

Highlander Silver Announces Results of Annual General Meeting of Shareholders

Kyivstar and Ukraine’s Securities Regulator Sign Memorandum to Advance Capital Markets Development and Expand Investment Access